S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Biden's Plan to Confiscate Your Cash? (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Biden's Plan to Confiscate Your Cash? (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Biden's Plan to Confiscate Your Cash? (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Biden's Plan to Confiscate Your Cash? (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Biden's Plan to Confiscate Your Cash? (Ad)
NASDAQ:OMER

Omeros - OMER News Headlines

$6.74
-0.39 (-5.47%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$6.66
$6.96
50-Day Range
$1.92
$7.46
52-Week Range
$1.86
$16.57
Volume
563,448 shs
Average Volume
985,271 shs
Market Capitalization
$422.80 million
P/E Ratio
2.17
Dividend Yield
N/A
Price Target
$11.20
Get Omeros News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter.

OMER Media Mentions By Week

OMER Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OMER
News Sentiment

0.97

0.63

Average
Medical
News Sentiment

OMER News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OMER Articles
This Week

11

4

OMER Articles
Average Week



SourceHeadline
marketbeat.com logoCantor Fitzgerald Analysts Boost Earnings Estimates for Omeros Co. (NASDAQ:OMER)
marketbeat.com - August 15 at 2:17 AM
finance.yahoo.com logoOmeros reports growing Omidria sales after deal with British eye care company
finance.yahoo.com - August 10 at 9:38 PM
seekingalpha.com logoOmeros Corporation (OMER) CEO Gregory Demopulos on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 10 at 6:36 AM
businesswire.com logoOmeros Corporation Reports Second Quarter 2022 Financial Results - Business Wire
businesswire.com - August 9 at 6:28 PM
finance.yahoo.com logoOmeros Corporation Reports Second Quarter 2022 Financial Results
finance.yahoo.com - August 9 at 6:28 PM
MarketBeat logoOmeros (OMER) Scheduled to Post Quarterly Earnings on Tuesday
americanbankingnews.com - August 8 at 7:08 AM
MarketBeat logoAnalysts Set Omeros Co. (NASDAQ:OMER) Target Price at $10.25
americanbankingnews.com - August 6 at 2:55 AM
businesswire.com logoOmeros Corporation to Announce Second Quarter Financial Results on August 9, 2022 - Business Wire
businesswire.com - August 4 at 12:23 PM
finance.yahoo.com logoOmeros Corporation to Announce Second Quarter Financial Results on August 9, 2022
finance.yahoo.com - August 4 at 12:23 PM
finance.yahoo.com logoWall Street Analysts See a 126% Upside in Omeros (OMER): Can the Stock Really Move This High?
finance.yahoo.com - August 4 at 12:23 PM
MarketBeat logoOmeros (NASDAQ:OMER) Stock Price Crosses Above 200 Day Moving Average of $4.60
americanbankingnews.com - August 2 at 2:26 AM
nasdaq.com logoHealth Care Sector Update for 07/29/2022: XLV, IMGN, VNRX, AMLX, OMER - Nasdaq
nasdaq.com - July 30 at 8:21 PM
benzinga.com logoRecap Of Friday's Biotech Catalysts - End of The Day Summary - Benzinga
benzinga.com - July 29 at 9:10 PM
nasdaq.com logoWhy The Trade Desk Stock Got Crushed on Friday - Nasdaq
nasdaq.com - July 29 at 4:09 PM
fool.com logoWhy Omeros Corporation Stock Is Marching Higher Today - The Motley Fool
fool.com - July 29 at 4:09 PM
fool.com logoWhy Omeros Corporation Stock Is Marching Higher Today
fool.com - July 29 at 3:11 PM
marketwatch.com logoOmeros Gets FDA Orphan-Drug Designation for OMS906 in PNH >OMER - MarketWatch
marketwatch.com - July 29 at 11:09 AM
finance.yahoo.com logoFDA Grants Orphan Drug Designation to Omeros’ MASP-3 Inhibitor OMS906 for Treatment of Paroxysmal Nocturnal Hemoglobinuria
finance.yahoo.com - July 29 at 11:09 AM
seekingalpha.com logoOMER stock gains on FDA's Orphan Drug designation for PNH candidate (NASDAQ:OMER) - Seeking Alpha
seekingalpha.com - July 28 at 8:08 PM
seekingalpha.com logoAfter gaining 69% in single trading day, Omeros stock gives back some gains (NASDAQ:OMER) - Seeking Alpha
seekingalpha.com - July 5 at 6:07 PM
fool.com logoWhy Omeros Stock Is Freefalling Today - The Motley Fool
fool.com - July 5 at 6:07 PM
finance.yahoo.com logoWhy Omeros Stock Is Freefalling Today
finance.yahoo.com - July 5 at 6:07 PM
nasdaq.com logoPre-market Movers: BOXD, NN, ARR, SPRC, TOP… - Nasdaq
nasdaq.com - June 23 at 7:39 AM
finance.yahoo.com logoCyclacel Pharmaceuticals Announces That Kenneth M. Ferguson, Ph.D. Was Elected to Its Board of Directors - Yahoo Finance
finance.yahoo.com - June 22 at 9:17 AM
finance.yahoo.com logoOmeros Announces Webcast Details for Annual Meeting of Shareholders
finance.yahoo.com - June 15 at 10:23 AM
seekingalpha.com logoDBV, Rubius top healthcare gainers; Rigel, Cosmos lead losers' pack - Seeking Alpha
seekingalpha.com - June 8 at 6:17 PM
seekingalpha.com logoOmeros slips to 52-week low as stock down 9% (NASDAQ:OMER) - Seeking Alpha
seekingalpha.com - June 8 at 6:17 PM
seekingalpha.com logoRussell 3000 rejig: CLOV, AUPH among added, ASXC, CLVS among deleted - Seeking Alpha
seekingalpha.com - June 6 at 12:10 PM
seekingalpha.com logoInovio Pharma, Bionano Genomics among health care stocks to join Russell Microcap Index - Seeking Alpha
seekingalpha.com - June 6 at 12:10 PM
streetinsider.com logoSpherix Global Insights Announces Entry into Asia-Pacific Research with Upcoming IgA Nephropathy Market and Pipeline Assessment in Japan - StreetInsider.com
streetinsider.com - June 2 at 7:24 PM
seekingalpha.com logoOmeros Stock: Speculative Biotech Opportunity On Death's Door (NASDAQ:OMER) - Seeking Alpha
seekingalpha.com - June 2 at 3:40 AM
seekingalpha.com logoOmeros Corporation (OMER) CEO Greg Demopulos on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 10 at 10:44 PM
businesswire.com logoOmeros Corporation Reports First Quarter 2022 Financial Results - Business Wire
businesswire.com - May 10 at 5:44 PM
finance.yahoo.com logoOmeros Corporation Reports First Quarter 2022 Financial Results
finance.yahoo.com - May 10 at 5:43 PM
benzinga.com logoOmeros Earnings Preview - Benzinga - Benzinga
benzinga.com - May 9 at 4:01 PM
finance.yahoo.com logoOmeros Corporation to Announce First Quarter Financial Results on May 10, 2022
finance.yahoo.com - May 4 at 1:20 PM
nasdaq.com logoOmeros vs. Binance Coin: Price Relationship Crosses Threshold - Nasdaq
nasdaq.com - May 3 at 8:37 PM
seekingalpha.com logoOmeros: The Weight Of The Wait, A Conundrum - Seeking Alpha
seekingalpha.com - May 2 at 10:34 PM
businesswire.com logoOmeros Announces Journal of Clinical Oncology Publication Detailing Pivotal Trial Results for Narsoplimab in HSCT-TMA - Business Wire
businesswire.com - April 20 at 4:06 PM
finance.yahoo.com logoOmeros Announces Journal of Clinical Oncology Publication Detailing Pivotal Trial Results for Narsoplimab in HSCT-TMA
finance.yahoo.com - April 20 at 11:05 AM
benzinga.com logoHuntington's Disease Treatment Market Size, Share, Insights, and Forecast to 2027 - Benzinga - Benzinga
benzinga.com - March 24 at 9:45 AM
fool.com.au logoWhat dragged on the Aussie Broadband (ASX:ABB) share price today? - The Motley Fool Australia
fool.com.au - March 16 at 4:23 AM
uk.finance.yahoo.com logoNew LED tool developed by scientists that spots dental cavities before they even start - Yahoo Finance UK
uk.finance.yahoo.com - March 10 at 3:54 AM
uk.finance.yahoo.com logoReport: Group of Russian NHLers couldn't agree on statement on Ukraine invasion - Yahoo Finance UK
uk.finance.yahoo.com - March 9 at 2:09 AM
uk.finance.yahoo.com logoCRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2022 Annual Meeting - Yahoo Finance UK
uk.finance.yahoo.com - March 8 at 9:09 PM
uk.finance.yahoo.com logoRussia faces further sanctions as investors dash for exit - Yahoo Finance UK
uk.finance.yahoo.com - March 8 at 9:09 PM
uk.finance.yahoo.com logoBank transfer scams are costing victims £28,000 every hour - Yahoo Finance UK
uk.finance.yahoo.com - March 8 at 9:09 PM
uk.finance.yahoo.com logoShould I bother waiting for the 2023 Lloyds dividend? - Yahoo Finance UK
uk.finance.yahoo.com - March 8 at 4:04 PM
benzinga.com logoOmeros: Q4 Earnings Insights - Benzinga
benzinga.com - March 1 at 9:12 PM
businesswire.com logoOmeros Corporation Reports Fourth Quarter and Year-End 2021 Financial Results - Business Wire
businesswire.com - March 1 at 9:12 PM
finance.yahoo.com logoOmeros Corporation Reports Fourth Quarter and Year-End 2021 Financial Results
finance.yahoo.com - March 1 at 4:12 PM
Get Omeros News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:OMER) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.